HSPB1 and non-small cell lung carcinoma: Chromatin immunoprecipitation (ChIP)-qPCR assays highlighted that downregulating HSPB1 decreases the expression of histone modifications (H3K27ac, H3K4me1) at the MED29 promoter, suggesting that AS-tDR-007333 may be a promising potential therapeutic target for NSCLC [74].